Relativity Acquisition Corp. Announces Instinct Bio’s SEC Filing for Proposed Business Combination

Las Vegas, NV, Tokyo, Japan — September 15, 2025 — Leads & Copy — Relativity Acquisition Corp. announced that Instinct Bio Technical Company Inc. publicly filed a registration statement with the SEC on September 8, 2025, regarding Relativity’s proposed business combination with Instinct Brothers Co., Ltd., a stem cell skincare and wellness company based in Tokyo, Japan. The Form F-4, including a preliminary proxy statement/prospectus, offers details on the proposed Business Combination and shareholder vote and is available on the SEC’s website.

Upon closing, the combined company will operate as Instinct Bio Technical Company Holdings Inc. and intends to list on the NASDAQ Stock Exchange under the ticker symbol ‘BIOT’.

Instinct Brothers, founded in 2011, specializes in stem cell skincare and wellness products. Relativity Acquisition Corp. is a blank check company formed for effecting a merger or similar business combination.

Relativity and Instinct Bio have filed a registration statement on Form F-4 with the SEC, including a preliminary prospectus and proxy statement. Relativity’s investors and stockholders are advised to read the Form F-4 and other documents filed with the SEC.

Relativity stockholders can obtain copies of the documents by directing a request to Relativity Acquisition Corp. or at the SEC’s website.

Relativity and Instinct Bio, along with their directors and officers, may be participants in soliciting proxies of Relativity’s stockholders. Security holders can find information on the names, affiliations, and interests of Relativity’s and Instinct Bio’s executive officers and directors in the F-4 and other relevant materials filed with the SEC.

This press release does not constitute an offer to sell or a solicitation of an offer to buy any securities.

This press release contains forward-looking statements that are subject to risks and uncertainties.

Contact Information:
Instinct Bio Technical Co., Ltd.
Email: ir@instinct-biot.com

Relativity Acquisition Corp.
Email: info@relativityacquisitions.com

Source: Relativity Acquisition Corp.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.